Cytovance® Biologics Announces the Company is Providing Antibody cGMP Manufacturing for ImmunoGen, Inc.
Cytovance® Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced that ImmunoGen, Inc., a biotechnology company developing targeted anticancer therapeutics, has been added to its diverse and growing client portfolio. ImmunoGen chose Cytovance for process development, cell banking, and cGMP manufacturing of a proprietary ImmunoGen antibody. "We are very pleased to partner with ImmunoGen and provide manufacturing excellence to their products," said Darren Head President and CEO of Cytovance Biologics. "Our relationship with ImmunoGen is an excellent example of our business model, value, services and state–of–the–art facilities."
ImmunoGen´s project is executed out of Cytovance´s multi–product cGMP production facility in Oklahoma City. The 44,000 sq. ft. facility meets the latest international regulatory standards and is custom–designed for efficient and cost–effective production. Cytovance specializes in the execution of clinical production of antibody and recombinant protein products derived from cell culture at scales up to 500L (w/v) from both fed–batch and perfusion processes. "Our excellent working relationship with ImmunoGen´s technical and Quality personnel has contributed directly to successful results from technology transfer through cell banking and cGMP manufacturing," said Steven Perry, Vice President of Manufacturing Operations for Cytovance Biologics. "We look forward to continued collaboration with ImmunoGen."
Cytovance was founded to help biopharmaceutical companies advance recombinant protein and antibody products rapidly and cost–effectively from the bench, through clinical development and into the international marketplace The company´s approach couples considerable client–side experience with the necessary technical and operational expertise to deliver precision science, agile manufacture, and reasonable business that meet international regulatory standards and facilitate efficient completion of clinical development.
About Cytovance Biologics
Cytovance Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. An experienced management team formed the company to address the biotechnology industry´s increasing needs for full–service manufacturing capacity at the clinical and early commercial scale. In addition to its cGMP manufacturing services, the company offers process development, cGMP cell banking and support services from its Oklahoma City, Okla. facilities. For more information on Cytovance, visit www.cytovance.com.